Afterplay as a treatment for premature ejaculation

Afterplay as a therapeutic modality in premature ejaculation : A prospective randomized placebo controlled two arm study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112551

Enrollment

100

Registered

2026-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N538- Other male sexual dysfunction

Interventions

Intervention1: Afterplay (Intervention agent), Placebo (comparator agent): Afterplay is used as therapeutic tool for PE Control Intervention1: Placebo: Placebo

Eligibility

Inclusion criteria

Inclusion criteria: All patients with PE

Exclusion criteria

Exclusion criteria: Comorbidities, psychosexual dysfunction other than PE

Design outcomes

Primary

Measure	Time frame
Change in PEDT score and IELT from baseline to the end of the studyTimepoint: 4 weeks, 6 months	—

Secondary

Measure	Time frame
Any new onset sexual dysfunction if anyTimepoint: During the study period	—

Countries

India

Contacts

Public ContactGajanan Bhat

TSSSHKIMS

gajubhatru@gmail.com9448068350

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026